Khiron Life Sciences Corp., a Canada-based company engaged in alternative medicine sector, announced that Joel Friedman has resigned as Chief Financial Officer. “Joel Friedman, has resigned as Chief Financial Officer of the Company for personal reasons,” the company said in its release. Khiron’s board of directors has appointed Swapan Kakumanu of RTB LLP to the role of Interim…